SOLIGENIX, INC.(SNGX)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
SOLIGENIX, INC. (SNGX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SNGX at 9.8/100 on a 32-signal composite quality model, placing it at rank #2,912 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of SNGX by reported 13-F value include CITADEL ADVISORS, JANE STREET GROUP, XTX Topco Ltd, based on the most recent SEC filings. SNGX trades on the Nasdaq exchange and files with the SEC under CIK 812796. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNGX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SOLIGENIX, INC. directly from SEC EDGAR.
AI Quality Score
9.8/100
AI Rank
#2,912
Net Income
$-2.0M
SNGX key financials by period
SOLIGENIX, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2024
10-K
$119.4K
$-8.3M
—
FY 2023
10-K
$839.4K
$-6.1M
—
FY 2022
10-K
$948.9K
$-13.8M
—
FY 2021
10-K
$824.3K
$-12.6M
—
FY 2020
10-K
$2.4M
$-17.7M
—
FY 2019
10-K
$4.6M
$-9.4M
—
Institutions holding SNGX
Institutional investors reporting a position in SOLIGENIX, INC. on SEC Form 13F.
